F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia
Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.